Cytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining. The firm is developing small molecule drug candidates specifically engineered to impact muscle function and contractility. Its clinical-stage drug candidates include omecamtiv mecarbil, a novel cardiac myosin activator, CK-136, a novel cardiac troponin activator, reldesemtiv, a novel fast skeletal muscle troponin activator, aficamten, a novel cardiac myosin inhibitor, and CK-3772271, a novel cardiac myosin inhibitor. The company was founded by Ronald D. Vale, Lawrence S. B. Goldstein, James H. Sabry, and James A. Spudich in 1997 and is headquartered in South San Francisco, CA.

Glaxo Group Ltd. operates through its subsidiary Glaxo Laboratories Ltd. that engages in the production of food products for infants such as Ostermilk, Complan, Casilan, Farex. Glaxo Group Ltd. was formerly known as Glaxo Laboratories Ltd. and changed its name to Glaxo Group Ltd. in 1962. The company is based in Brentford, United Kingdom. Glaxo Group Ltd. operates as a subsidiary of Glaxosmithkline plc.

UCLB is the commercialisation company of UCL and its partner NHS Trusts. They bring to market truly world-leading, world-changing technologies, innovations that have a real and positive impact on people’s lives. UCLB the access point to the wealth of innovation and intellectual property emanating from UCL and partner hospitals including University College Hospital, Great Ormond Street Hospital, Royal Free Hospital and Moorfields Eye Hospital. They offer a number of services to assist the technology development process, from consultancy through to collaborative research, IP licensing and the creation of spinout companies and joint ventures to maximise the commercial potential of new discoveries, materials and processes.

Ventana Medical Systems, Inc., is a world leader and innovator of tissue-based diagnostic solutions for patients worldwide. The company passionately pursues its mission to improve the lives of all patients afflicted with cancer. Ventana Medical Systems discover, develop, and deliver medical diagnostic systems and biopsy based cancer tests that are shaping the future of healthcare. As the leading supplier of cancer diagnostic systems to the pathology market, Ventana manufactures over 220 cancer tests with related instruments right here in southern Arizona for 80 countries, and most importantly, for 4 million people afflicted with cancer yearly around the world. Ventana products provide healthcare professionals with a total solution for all critical steps involved in the analysis of tissue biopsies. This pioneering company also offers premier workflow solutions to improve laboratory efficiency and preserve patient safety. Ventana is committed to accelerating the discovery and development of new cancer tests that allow pathologists to analyze patient samples at the molecular level to help determine the best course of therapy for each individual patient. Ventana enables this with its global leadership as the number one Pharma Industry Partner of Choice in the development and commercialization of companion diagnostics for cancer patients. Ventana Medical Systems is a member of the Roche Group that is drawing on powerful partnerships with world-class scientific institutions.

Cytognomix develops software-based solutions and reagents for clinical genomics.

Sanofi Genzyme is the specialty care global business unit of Sanofi, focused on rare diseases, multiple sclerosis, immunology, and oncology. They help people with debilitating and complex conditions that are often difficult to diagnose and treat. They are dedicated to discovering and advancing new therapies, providing hope to patients and their families around the world. Genzyme became part of Sanofi in 2011. While continuing to focus on rare diseases, they also established ourselves as a leader in the field of multiple sclerosis. In 2016, their focus expanded to include Sanofi’s programs in oncology and immunology. Their approach is shaped by a long history of developing highly specialized treatments and forging close relationships with physician and patient communities. Founded as Genzyme in Boston in 1981, they rapidly grew to become one of the world’s leading biotechnology companies, recognized for their pioneering development of treatments for rare genetic disorders and their innovative contributions to medical science and biomanufacturing.

Venturedyne operates as a holding company of industrial manufacturing companies. The company manufactures and supplies environmental testing, test system integration, screening, and simulation equipment; HVAC equipment for sheet metal and mechanical contractors serving commercial, non-residential, and construction markets; and a line of magnetic separators and sweepers for applications, such as recycling, bulk processing, mining, concrete and demolition recycling, aggregate processing, and general industrial use. It also manufactures dings brakes for conveyors, door openers, machine drives, cranes, and a multitude of other applications that require rapid stopping and holding power; brick-making equipment, such as brick presses; and particle counters that validate and monitor airborne particles in controlled production environments.

UAB Research Foundation (doing business as UABRF), a subsidiary of The University of Alabama System, is a company headquartered in Birmingham, AL. The firm engages in identify, assess, and market commercially viable technology developed at The University of Alabama at Birmingham.

Leica Biosystems Imaging, Inc., a subsidiary of Danaher Corp., is a company headquartered in the United States that develops and manufactures scanning hardware.

UOP LLC operates as a supplier and technology licensor for the petroleum refining, gas processing and petrochemical production. Its products include catalysts and adsorbents. The firm offers design, commissioning, ongoing operations, and optimization services. The company was founded on June 17, 1914 and is headquartered in Des Plaines, IL.

Korea Institute of Industrial Technology is a South Korean private company that operates as research institute.

Slottsviken Fastighets AB engages in the acquisition, management and development of real properties in urban areas. It owns and manages properties in Molndal, Partille, and Kungalv counties. The company was founded on June 16, 1983 and is headquartered in Gothenburg, Sweden.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Tianjin Institute of Pharmaceutical Research Co., Ltd. engages in the in the development of various new products such as innovative drugs, generic drugs, new preparations, traditional Chinese medicines, and biological drugs with particular emphasis on the engineering and industrialization of new technologies to meet drug registration requirements. The company was founded in 1959 and is headquartered in Tianjin, China.

Tianjin Tiancheng New Drug Evaluation Co., Ltd., established on 2005-07-20, Business scope includes biological,medicine,medical instruments,digital information,Mechatronics,food,cosmetic,Health Supplies,Technology development of new materials,consult,Serve,transfer;Instrument Repair;business services;Wholesale and retail trade;Goods and technology import and export business;Own house rental.(The state has special franchise regulations,Execute according to regulations)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)